PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Anonymous $10 million gift to Henry Ford Health establishes lung cancer tissue repository, bolsters research

2023-11-28
(Press-News.org) As Lung Cancer Awareness Month comes to a close, Henry Ford Health is proud to announce it has received an anonymous gift of $10 million, which is poised to significantly advance lung cancer research at Henry Ford Cancer.

This transformative gift has enabled Henry Ford to establish a new lung cancer tissue biorepository, which is a facility that catalogs and stores biological samples for research. These samples – in this case, lung cancer tissue – are crucial for scientists who are studying the disease at a molecular level, which can lead to potential breakthroughs in the diagnosis and treatment of lung cancer for patients in Michigan and beyond.

This new lung cancer tissue biorepository strengthens Henry Ford’s position as a global leader in cancer research and mirrors the brain cancer tissue biorepository already in place at Henry Ford Cancer. Both facilities represent the institution's commitment to cutting-edge research and personalized medicine. The lung cancer biorepository will house tissue samples from a diverse patient population, providing a valuable resource for researchers.

This generous gift has also enabled the strategic expansion of Henry Ford’s specialized clinical trials program. These developments are an important part of the health system’s ability to drive innovation for the benefit of patients not only in Michigan, but also around the world.

The comprehensive lung cancer program at Henry Ford Health, renowned for its emphasis on early detection, patient support, advanced treatment options and translational research, continues to set benchmarks in medical excellence. With the support of this extraordinary gift, Henry Ford Health reaffirms its position at the forefront of lung cancer medicine and research, offering hope and new possibilities in the battle against the leading cause of cancer-related death in the U.S.

END


ELSE PRESS RELEASES FROM THIS DATE:

RCSI researchers develop material that reduces bacterial infection and speeds up bone healing

RCSI researchers develop material that reduces bacterial infection and speeds up bone healing
2023-11-28
28 November 2023: Researchers at RCSI University of Medicine and Health Sciences and Advanced Materials and Bioengineering Research Centre (AMBER) have developed a new surgical implant that has the potential to transform the treatment of complex bone infections. When implanted on an injured or infected bone, the material can not only speed up bone healing, it also reduces the risk of infections without the need for traditional antibiotics.  The newly published paper in the journal Advanced Materials, tackles the complex clinical problem of bone infection, ...

Contrast sensitivity of ON and OFF human retinal pathways in myopia

2023-11-28
Across the entire animal kingdom, visual images are processed by two major neuronal pathways that extract light and dark stimuli from visual scenes – ON (light on) and OFF (light off) pathways. Light stimuli are brighter than their background like a white cloud in a gray sky whereas dark stimuli are darker than the background like a black bird in a blue sky. The two pathways can extract stimuli with different contrasts but some pathways are more sensitive than others. In carnivores and rodents, ON pathways are more sensitive ...

DFW air quality continues to miss EPA goals for safety

DFW air quality continues to miss EPA goals for safety
2023-11-28
Air quality in the Dallas-Fort Worth metropolitan area continues to miss safety levels set by the Environmental Protection Agency (EPA) and is unlikely to meet EPA goals anytime soon, according to new research from The University of Texas at Arlington. Purnendu “Sandy” Dasgupta, professor of chemistry and biochemistry and the Hamish Small Chair of Ion Analysis at The University of Texas at Arlington, said the region’s low population density, lack of widespread public transportation and reliance on cars contribute to its poor air quality. Its ozone values have exceeded safety levels set by the EPA for the last 20 years. “Compared ...

Many owners see little value in storing their firearms securely

2023-11-28
With more than 400 million privately owned firearms in circulation across the United States, gun violence prevention efforts have emphasized secure firearm storage as a method for preventing injury and death. But some owners may not see the value in doing so, according to Rutgers researchers. Despite evidence that secure storage can effectively reduce the risk of suicide and unintentional shootings, many firearm owners typically keep at least one firearm stored loaded and unlocked, quickly accessible in case of home invasion. ...

PCORI approves $80.5 million for health research using novel approaches to tackle social and clinical care factors that contribute to maternal health inequities

PCORI approves $80.5 million for health research using novel approaches to tackle social and clinical care factors that contribute to maternal health inequities
2023-11-28
WASHINGTON, D.C. – The Patient-Centered Outcomes Research Institute (PCORI) today announced funding awards totaling $80.5 million to support four new, ambitious patient-centered comparative clinical effectiveness research (CER) studies focused on both the health care and social factors that contribute to inequities in maternal morbidity and mortality. The trials are among 30 CER studies and related projects recently approved for PCORI funding.    Awarded through an innovative PCORI funding opportunity known as Partner for its focus on partnering research institutions and community organizations ...

Ohio State receives $14 million to study optimal aspirin therapy in pregnancy

2023-11-28
COLUMBUS, Ohio – A research team at The Ohio State University Wexner Medical Center and College of Medicine has been approved for a $14 million award from the Patient-Centered Outcomes Research Institute (PCORI) to study whether a higher daily dose of aspirin is more effective in decreasing the risk of dangerous blood pressure complications among some pregnant people. During pregnancy, people are at risk of developing preeclampsia and gestational hypertension. Both disorders are characterized by high blood pressure and bring with them the potential for injury to the brain, lungs, kidneys and liver. These hypertensive disorders ...

University of Colorado Department of Medicine cardiologist lands $7 million funding award for nationwide study on improving heart-failure treatment

2023-11-28
Larry Allen, MD, chief of the Division of Cardiology at the University of Colorado School of Medicine, will receive a funding award for a nationwide study that he hopes will lead to more heart-failure patients getting the life-saving medications they need. The $7 million in support, announced Nov. 28, is from the nonprofit Patient-Centered Outcomes Research Institute (PCORI), the leading U.S. funder of comparative clinical effectiveness research centered on patients. Allen, a professor of cardiology in the CU Department of Medicine, says the funding award includes $2.5 million in direct support to CU, another $2.5 million to four other ...

PCORI approves $225 million in funding for dozens of health research studies and related projects

PCORI approves $225 million in funding for dozens of health research studies and related projects
2023-11-28
WASHINGTON, D.C. – The Patient-Centered Outcomes Research Institute (PCORI) today announced the approval of funding awards totaling $225 million, which include $207 million to support 20 new patient-centered comparative clinical effectiveness research (CER) studies. By comparing various approaches to care, these studies will help fill evidence gaps related to maternal illness and death, adolescent mental health, delirium in older adults, cardiovascular disease and a range of other high-burden health conditions. Four awards include support for large patient-centered CER studies in which community organizations and research institutions as coequal partners will tackle ...

Opioids vs. NSAIDS: which are safest and most effective for treating pain following surgery?

Opioids vs. NSAIDS: which are safest and most effective for treating pain following surgery?
2023-11-28
LOS ANGELES (November 28, 2023)—Thousands of adolescents and young adults have outpatient surgery every day and are sent home with pain medication. Although the need for medication is clear, the best way to treat the pain is not. A new study led by investigators at the University of Michigan and Children’s Hospital Los Angeles will compare two treatment regimens—one that uses a regimen of non-opioid medication and another that adds a low-dose opioid—to determine the safest and most effective way to treat pain in adolescents and young adults recovering from common outpatient surgeries. In the past, opioids ...

Slash-and-burn agriculture can increase forest biodiversity

Slash-and-burn agriculture can increase forest biodiversity
2023-11-28
The slash-and-burn agriculture practiced by many Indigenous societies across the world can actually have a positive impact on forests, according to a new study done in Belize.   Researchers found that in areas of the rainforest in which Indigenous farmers using slash-and-burn techniques created intermediate-sized farm patches – neither too small nor too large – there were increases in forest plant diversity.   This contradicts what had long been the standard view in the past, promoted by the ...

LAST 30 PRESS RELEASES:

Are patients undergoing surgery for early-stage cancer at risk of persistent opioid use?

Black youth, especially Black girls, use mental health services less than their White peers

Canada must protect youth from sports betting advertising

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

[Press-News.org] Anonymous $10 million gift to Henry Ford Health establishes lung cancer tissue repository, bolsters research